Contrast-Induced Nephropathy: What We Know, What We Think We Know, and What We Don't Know

ABSTRACT

Contrast-induced nephropathy is a common but poorly understood problem. A large body of literature devoted to the subject is replete with contradictions and conflicting reports. The purpose of this article is to summarize our current understanding of the problem by reviewing some of the best studies done to date. Recommendations based on the current literature are also provided.

Contrast - nephropathy - contrast-induced nephropathy - review - renal insufficiency - radiology

REFERENCES

• 1 McCullough P A, Wolyn R, Rocher L L, Levin R N, O'Neill W W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.  Am J Med. 1997;  103 368-375
• 2 Rihal C S, Textor S C, Grill D E et al.. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.  Circulation. 2002;  105 2259-2264
• 3 Rudnick M R, Berns J S, Cohen R M, Goldfarb S. Contrast media-associated nephrotoxicity.  Semin Nephrol. 1997;  17 15-26
• 4 Rudnick M R, Goldfarb S, Wexler L et al.. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.  Kidney Int. 1995;  47 254-261
• 5 Barrett B J, Carlisle E J. Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.  Radiology. 1993;  188 171-178
• 6 Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents.  N Engl J Med. 1994;  331 1416-1420
• 7 Stone G W, McCullough P A, Tumlin J A et al.. CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.  JAMA. 2003;  290 2284-2291
• 8 Carraro M, Mancini W, Artero M et al.. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration.  Nephrol Dial Transplant. 1996;  11 444-448
• 9 Mueller C, Buerkle G, Buettner H J et al.. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.  Arch Intern Med. 2002;  162 329-336
• 10 Allaqaband S, Tumuluri R, Malik A M et al.. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.  Catheter Cardiovasc Interv. 2002;  57 279-283
• 11 Spinosa D J, Matsumoto A H, Angle J F et al.. Gadolinium-based contrast and carbon dioxide angiography to evaluate renal transplants for vascular causes of renal insufficiency and accelerated hypertension.  J Vasc Interv Radiol. 1998;  9 909-916
• 12 Spinosa D J, Matsumoto A H, Angle J F, Hagspiel K D, McGraw J K, Ayers C. Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO₂-enhanced renal angiography for diagnosis and percutaneous treatment.  Radiology. 1999;  210 663-672
• 13 Spinosa D J, Angle J F, Hagspiel K D, Kern J A, Hartwell G D, Matsumoto A H. Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO₂ angiography in patients with renal insufficiency.  J Vasc Interv Radiol. 2000;  11 35-43
• 14 Ailawadi G, Stanley J C, Williams D M, Dimick J B, Henke P K, Upchurch Jr G R. Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia.  J Vasc Surg. 2003;  37 346-352
• 15 Sam II A D, Morasch M D, Collins J, Song G, Chen R, Pereles F S. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.  J Vasc Surg. 2003;  38 313-318
• 16 Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?.  Radiology. 2002;  223 311-318 discussion 328-329
• 17 Caridi J G, Stavropoulos S W, Hawkins Jr I F. CO₂ digital subtraction angiography for renal artery angioplasty in high-risk patients.  AJR Am J Roentgenol. 1999;  173 1551-1556
• 18 Kessel D O, Robertson I, Patel 5th J. et al . Carbon-dioxide-guided vascular interventions: technique and pitfalls.  Cardiovasc Intervent Radiol. 2002;  25 476-483
• 19 Cigarroa R G, Lange R A, Williams R H, Hillis L D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.  Am J Med. 1989;  86 649-652
• 20 Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.  Nephrol Dial Transplant. 1998;  13 358-362
• 21 Vogt B, Ferrari P, Schonholzer C et al.. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.  Am J Med. 2001;  111 692-698
• 22 Marenzi G, Marana I, Lauri G et al.. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.  N Engl J Med. 2003;  349 1333-1340
• 23 Merten G J, Burgess W P, Gray L V et al.. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.  JAMA. 2004;  291 2328-2334
• 24 Stevens M A, McCullough P A, Tobin K J et al.. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.  J Am Coll Cardiol. 1999;  33 403-411
• 25 Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.  N Engl J Med. 2000;  343 180-184
• 26 Baker C S, Wragg A, Kumar S, De Palma R, Baker L R, Knight C J. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.  J Am Coll Cardiol. 2003;  41 2114-2118
• 27 Kay J, Chow W H, Chan T M et al.. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.  JAMA. 2003;  289 553-558
• 28 Briguori C, Manganelli F, Scarpato P et al.. Acetylcysteine and contrast agent-associated nephrotoxicity.  J Am Coll Cardiol. 2002;  40 298-303
• 29 Webb J G, Pate G E, Humphries K H et al.. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.  Am Heart J. 2004;  148 422-429
• 30 Oldemeyer J B, Biddle W P, Wurdeman R L, Mooss A N, Cichowski E, Hilleman D E. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.  Am Heart J. 2003;  146 E23
• 31 Durham J D, Caputo C, Dokko J et al.. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.  Kidney Int. 2002;  62 2202-2207
• 32 Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude F J, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.  Lancet. 2003;  362 598-603
• 33 Nallamothu B K, Shojania K G, Saint S et al.. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis.  Am J Med. 2004;  117 938-947
• 34 Kshirsagar A V, Poole C, Mottl A et al.. N-Acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.  J Am Soc Nephrol. 2004;  15 761-769
• 35 Aspelin P, Aubry P, Fransson S G, Strasser R, Willenbrock R, Berg K J. Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators . Nephrotoxic effects in high-risk patients undergoing angiography.  N Engl J Med. 2003;  348 491-499
• 36 Chalmers N, Jackson R W. Comparison of iodixanol and iohexol in renal impairment.  Br J Radiol. 1999;  72 701-703
• 37 Carraro M, Malalan F, Antonione R et al.. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial.  Eur Radiol. 1998;  8 144-147